BRUNETTI JLENIA

Jlenia
Brunetti
Dipartimento di Biotecnologie Mediche
Ricercatore Legge 240/10 - tempo determinato

Presentazione

Jlenia Brunetti is RTDB at the Department of Medical Biotechnology of the University of Siena. She’s been working for thirteen years at University of Siena as Research Associate, being involved in many projects focusing on the development of peptide molecules and in their biochemical and biological characterization. She has now a consolidated experience in coordinating people in the laboratory and their work.

Orari di ricevimento

Lunedì dalle 10:00 alle 11:00

Stanza 20-160 San Miniato

Telefonare 0577/232041 o inviare email a jlenia.brunetti@unisi.it per appuntamento

Contatti

jlenia.brunetti@unisi.it
0577-232041
Stanza virtuale G-Meet
Stanza virtuale Webex

Curriculum Vitae

cv

Attività didattica

ANNO ACCADEMICO DI ESPLETAMENTO: 2023/2024

ANNO ACCADEMICO DI ESPLETAMENTO: 2022/2023

ANNO ACCADEMICO DI ESPLETAMENTO: 2021/2022

Iscrizione agli esami

Attività di ricerca

Ultime pubblicazioni:

  • Cresti, L., Cappello, G., Vailati, S., Melloni, E., Brunetti, J., Falciani, C., et al. (2023). In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(9), 7967 [10.3390/ijms24097967]. - dettaglio
  • Alaverdian, D., Corradi, A.M., Sterlini, B., Benfenati, F., Murru, L., Passafaro, M., et al. (2023). Modelling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient-derived induced pluripotent stem cells. EPILEPTIC DISORDERS, 1-12 [10.1002/epd2.20065]. - dettaglio
  • Cresti, L., Falciani, C., Cappello, G., Brunetti, J., Vailati, S., Melloni, E., et al. (2022). Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs. SCIENTIFIC REPORTS, 12(1), 1-18 [10.1038/s41598-022-23841-2]. - dettaglio
  • Marianantoni, G., Meogrossi, G., Tollapi, E., Rencinai, A., Brunetti, J., Marruganti, C., et al. (2022). Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts. PHARMACEUTICS, 14(10), 1-15 [10.3390/pharmaceutics14102081]. - dettaglio
  • Cresti, L., Conte, G., Cappello, G., Brunetti, J., Falciani, C., Bracci, L., et al. (2022). Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: Antibacterial Activity and Toxicity In Vitro and In Vivo. PHARMACEUTICS, 15(1), 3 [10.3390/pharmaceutics15010003]. - dettaglio
Tutte le pubblicazioni